Article
Maternal and Fetal HLA Heterozygosity in Preeclampsia: Insights From a Large Multi-Ancestry Pregnancy Cohort.
HLA - 1 Sept 2026
Cao Chang, Maher Matthew, Hu Jie, Keating Brendan J, Burwick Richard M, Karumanchi S Ananth, Maxwell G Larry, Powe Camille E, McElrath Thomas F, Cantonwine David E, Serrano Norma, Colmenares Claudia, Casas Juan P, Saxena Richa, Gray Kathryn J
Abstract excerpt
Preeclampsia (PE) is a leading cause of maternal and neonatal morbidity, with immune dysregulation at the maternal-fetal interface central to its pathogenesis. The highly polymorphic HLA region mediates maternal immune tolerance of the semi-allogeneic fetus, yet the contribution of HLA diversity to PE risk remains poorly defined. Whether the HLA heterozygote advantage observed in other immune disorders is...
Read the complete abstract on PubMedTopics
- Humans
- Female
- Pregnancy
- Pre-Eclampsia
- Heterozygote
- Adult
